References
- Aranda-Hernandez J, Cirocco M, Marcon N (2014). Treatment of dysplasia in barrett esophagus. Clin Endosc, 47, 55-64. https://doi.org/10.5946/ce.2014.47.1.55
- Choi J, Kim SG, Kim JS, Jung HC, Song IS (2010). Comparison of endoscopic ultrasonograph (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc, 24, 1380-86. https://doi.org/10.1007/s00464-009-0783-x
- Feng JF, Huang Y, Chen QX (2013). Prognostic value of preoperative serum CA 242 in esophageal squamous cell carcinoma cases. Asian Pac J Cancer Prev, 14, 1803-6. https://doi.org/10.7314/APJCP.2013.14.3.1803
- Jiang JT, Zhang LF, Zhou B, et al (2012). Relationships of uPA and VEGF expression in esophageal cancer and microvascular density with tumorous invasion and metastasis. Asian Pac J Cancer Prev, 13, 3379-83. https://doi.org/10.7314/APJCP.2012.13.7.3379
- Kato H, Kuwano H, Nakajima M, et al (2002). Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer, 94, 921-8. https://doi.org/10.1002/cncr.10330
- Kim K, Park SJ, Kim BT, et al (2001). Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Sug, 71, 290-4. https://doi.org/10.1016/S0003-4975(00)02221-9
- Lee S, Yoo JH, Lee SW (2012). Kikuchi disease: differentiation from tuberculous lymphadenitis based on patterns of nodal necrosis on CT. AJNR Am J Neuroradiol, 33, 135-40. https://doi.org/10.3174/ajnr.A2724
- Lerut T, Flamen P, Ectors N, et al (2000). Histopathologic validation of lymph node staging with FDG PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg, 232, 743-52. https://doi.org/10.1097/00000658-200012000-00003
- Li YM, Lin Q, Zhao L, et al (2014). Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients. Asian Pac J Cancer Prev, 15, 1369-73. https://doi.org/10.7314/APJCP.2014.15.3.1369
- Luketich JD, Schauer PR, Meltzer CC, et al (1997). Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg, 64, 765-9. https://doi.org/10.1016/S0003-4975(97)00624-3
- Ma JB, Chen EC, Song YP, et al (2013). Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma. Asian Pac J Cancer Prev, 14, 2477-81. https://doi.org/10.7314/APJCP.2013.14.4.2477
- Manabe O, Hattori N, Hirata K, et al (2013). Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. J Nucl Med, 54, 670-6. https://doi.org/10.2967/jnumed.112.110304
- Mizowaki T, Nishimura Y, Shimada Y, et al (1996). Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer:evaluation by computed tomography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys, 36, 1091-98. https://doi.org/10.1016/S0360-3016(96)00425-7
- Okada M, Murakami T, Kumano S, et al (2009). Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med, 23, 73-80. https://doi.org/10.1007/s12149-008-0209-1
- Saha S, Dehn TC (2001). Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. Dis Esophagus, 14, 32-36. https://doi.org/10.1111/j.1442-2050.2001.00148.x
- Schreurs LM, Pultrum BB, Koopmans KP, et al (2008). Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer. Anticancer Res, 28, 1867-73.
- Tanaka T, Matono S, Mori N, Shirouzu K, Fujita H (2013). T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy. Ann Surg Oncol, 21, 932-8.
- Yasuda S, Raja S, Hubner KF (1995). Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case. Surg Today, 25, 261-4. https://doi.org/10.1007/BF00311538
- Yen TJ, Chung CS, Wu YW, et al (2012). Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal cell carcinoma. Dis Esophagus, 25, 40-47. https://doi.org/10.1111/j.1442-2050.2011.01204.x
- Yoon YC, Lee KS, Shim YM, et al (2003). Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology, 227, 764-70. https://doi.org/10.1148/radiol.2281020423
- You JJ, Wong RK, Darling G, et al (2013). Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer. J Thorac Oncol, 8, 1563-69. https://doi.org/10.1097/JTO.0000000000000006
Cited by
- Role of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapy vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10899
- Use of Imaging for GI Cancers vol.33, pp.16, 2015, https://doi.org/10.1200/JCO.2014.60.2847
- Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo vol.49, pp.3, 2017, https://doi.org/10.4143/crt.2015.485
- Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio vol.28, pp.1, 2018, https://doi.org/10.1007/s00330-017-4935-4